These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 7516094

  • 41. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
    Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR.
    J Clin Oncol; 1995 Aug; 13(8):1880-92. PubMed ID: 7636530
    [Abstract] [Full Text] [Related]

  • 42. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
    Hayashi Y, Kato M, Matsuura T, Yamada Y, Adachi S, Ito G, Yamamoto K, Takeuchi T.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Dose-dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinoma.
    Page RD, Smith FP, Geils GF, Beall CL, Fridman M, Allen BJ.
    Cancer; 2005 Nov 01; 104(9):1956-61. PubMed ID: 16177986
    [Abstract] [Full Text] [Related]

  • 45. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T, Lafitte JJ, Thiriaux J, VanHoutte P, Lecomte J, Efremidis A, Koumakis G, Giner V, Richez M, Corhay JL, Wackenier P, Lothaire P, Mommen P, Ninane V, Sculier JP, European Lung Cancer Working Party.
    Lung Cancer; 2004 Sep 01; 45(3):339-48. PubMed ID: 15301874
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Dose intensity chemotherapy in lung cancer].
    Takada M, Fukuoka M, Negoro S, Masuda N, Kudo S.
    Gan To Kagaku Ryoho; 1990 Oct 01; 17(10):2005-12. PubMed ID: 1699498
    [Abstract] [Full Text] [Related]

  • 48. Intensive chemotherapy for anaplastic thyroid carcinoma: combination of cisplatin, doxorubicin, etoposide and peplomycin with granulocyte granulocyte colony-stimulating factor support. Chemotherapy Committee, The Japanese Society of Thyroid Surgery.
    Jpn J Clin Oncol; 1995 Oct 01; 25(5):203-7. PubMed ID: 7474408
    [Abstract] [Full Text] [Related]

  • 49. The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
    Bunn PA.
    Semin Oncol; 1989 Aug 01; 16(4 Suppl 6):10-21. PubMed ID: 2548280
    [Abstract] [Full Text] [Related]

  • 50. Induction combination chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
    Herse B, Dalichau H, Wörmann B, Hemmerlein B, Schmidberger H, Hess CF, Hannemann P, Criée CP, Hiddemann W, Griesinger F.
    Thorac Cardiovasc Surg; 1998 Oct 01; 46(5):298-302. PubMed ID: 9885122
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
    Alexopoulos K, Kouroussis C, Androulakis N, Papadakis E, Vaslamatzis M, Kakolyris S, Samelis G, Patila E, Vossos A, Samantas E, Georgoulias V.
    Cancer Chemother Pharmacol; 1999 Oct 01; 43(3):257-62. PubMed ID: 9923557
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. r-metHuG-CSF support to ifosfamide, cisplatin, etoposide chemotherapy in non-small cell lung cancer.
    Gautier V, Pujol JL, Zinaï A, Michel FB.
    Lung Cancer; 1996 Jun 01; 14(2-3):343-51. PubMed ID: 8794415
    [Abstract] [Full Text] [Related]

  • 55. Chemoradiation in advanced nonsmall cell lung cancer.
    Pisch J, Berson AM, Malamud S, Beattie EJ, Harvey J, Vikram B.
    Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):183-8. PubMed ID: 7642417
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Effect of timing of granulocyte-colony stimulating factor administration on leukopenia induced by systemic chemotherapy in patients with non-small-cell lung cancer--multi-center randomized crossover study].
    Katakami N, Hasegawa T, Umeda B, Adachi S, Ishii N, Takada Y, Tsubota N, Nakano K, Tamura R, Nakai H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 May 30; 34(5):520-8. PubMed ID: 8753109
    [Abstract] [Full Text] [Related]

  • 59. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W, Mertelsmann R.
    Ann Oncol; 1997 Jan 30; 8(1):57-64. PubMed ID: 9093708
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.